Toshio Kokubo Selected Research

Immunoglobulin G (IgG)

1/2018

Fc engineering of anti-Nectin-2 antibody improved thrombocytopenic adverse event in monkey.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshio Kokubo Research Topics

Disease

2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 06/2013
2	Neoplasms (Cancer) 01/2018 - 06/2013
1	Sleep Initiation and Maintenance Disorders (Insomnia) 11/2019
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Breast Neoplasms (Breast Cancer) 06/2013
1	Anaphylaxis (Anaphylactic Shock) 09/2003
1	Edema (Dropsy) 09/2003
1	Hypersensitivity (Allergy) 09/2003
1	Inflammation (Inflammations) 09/2003
1	Atopic Dermatitis (Atopic Eczema) 10/2002
1	Asthma (Bronchial Asthma) 10/2002
1	Allergic Rhinitis 10/2002

Drug/Important Bio-Agent (IBA)

2	NectinsIBA 01/2018 - 06/2013
2	Monoclonal AntibodiesIBA 01/2018 - 06/2013
1	Hypnotics and Sedatives (Sedatives)IBA 11/2019
1	Immunoglobulin G (IgG)IBA 01/2018
1	EpitopesIBA 06/2013
1	2- (7- (3,4- dimethoxyphenyl)imidazo(1,2- c)pyrimidin- 5- ylamino)nicotinamideIBA 09/2003
1	Syk KinaseIBA 09/2003
1	AntigensIBA 09/2003
1	Niacinamide (Nicotinamide)FDA LinkGeneric 09/2003
1	IgE Receptors (Fc epsilon RI)IBA 10/2002
1	Anti-Allergic Agents (Antiallergic Agents)IBA 10/2002

Therapy/Procedure

2	Therapeutics 06/2013 - 10/2002
1	Oral Administration 09/2003